Acetaldehyde impairs mitochondrial glutathione transport in HepG2 cells through endoplasmic reticulum stress

Gastroenterology

Volumn 124, Issue 3, 2003, Pages 708-724

  Lluis, Josep M ^a   Colell, Anna ^a   García Ruiz, Carmen ^a   Kaplowitz, Nell ^b   Fernández Checa, José C ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 (2 OCTYLCYCLOPROPYL)OCTANOIC ACID 2 (2 METHOXYETHOXY)ETHYL ESTER; ACETALDEHYDE; ALCOHOL; CHOLESTEROL; CYCLOSPORIN A; GLUTATHIONE; HOMOCYSTEINE; MEVINOLIN; STEROL; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUNICAMYCIN;

ALCOHOL LIVER DISEASE; AMINO ACID TRANSPORT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CELL STRUCTURE; CELL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FLUIDIZATION; HUMAN; HUMAN CELL; KINETICS; MICHAELIS CONSTANT; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; STRESS;

EID: 0037370152     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2003.50089     Document Type: Article

References (54)

1. Lieber CS. Alcohol and the liver: an update. Gastroenterology 1994;106:1085-1105.
2. Shaw S, Jayatilleke E, Ross WA, Gordon ER, Lieber CS. Ethanol-induced lipid peroxidation by long term alcohol feeding and attenuation by methionine. J Lab Clin Med 1981;98:417-424.
3. Niemela O, Juvonen T, Parkkila S. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption. J Clin Invest 1991;87:1367-1374.
4. Fernández-Checa JC, Kaplowitz N, García-Ruiz C, Colell A. Importance and regulation of mitochondrial glutathione. Semin Liver Dis 1998;18:389-401.
5. Niemela O, Parkkila S, Herttuala S, Villanueva J, Ruebner B, Halsted C. Sequential acetaldehyde production, lipid peroxidation and fibrogenesis in micropig model of alcohol-induced liver disease, Hepatology 1995;22:1208-1214.
6. Ashak KG, Zimmerman HJ, Ray MB. Alcoholic liver disease: pathologic, pathogenic and clinical aspects. Alcohol Clin Exp Res 1991;15:45-66.
7. García-Ruiz C, Morales A, Colell A, Ballesta A, Rodés J, Kaplowitz N, Fernández-Checa JC. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes. J Clin Invest 1994;94:193-201.
8. Brenner DA, Chojkier M. Acetaldehyde increases collagen gene transcription in cultured human fibroblasts. J Biol Chem 1987;262:17690-17695.
9. Casini A, Cunningham M, Rojkind M, Lieber CS. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 1991;13:758-763.
10. Parés A, Potter J, Rennie L, Mezey E. Acetaldehyde activates the promoter of the mouse alpha 2(I) collagen gene. Hepatology 1994;19:498-503.
11. Anania F, Potter J, Rennie-Tankersley L, Mezey E. Activation by acetaldehyde of the promoter of the mouse alpha 2 (I) collagen gene when transfected into rat activated stellate cells. Arch Biochem Biophys 1996;331:187-193.
12. Anania FA, Potter J, Rennie-Tankersley L, Mezey E. Effects of acetaldehyde on nuclear protein binding to the nuclear factor I consensus sequence in the alpha 2 (I) collagen promoter. Hepatology 1995;21:1640-1648.
13. Miao K, Potter J, Anania FA, Rennie-Tankersley L, Mezey E. Effect of acetaldehyde on Sp1 binding and activation of the mouse alpha 2 (I) collagen promoter. Arch Biochem Biophys 1997;341:140-152.
14. Roman J, Colell A, Blasco C, Caballeria J, Pares A, Rodés J, Fernández-Checa JC. Differential role of ethanol and acetaldehyde in the induction of oxidative stress in HepG2 cells: effect on transcription factors AP-1 and NF-κB. Hepatology 1999;30:1473-1480.
15. Roman J, Giménez A, Lluis JM, Gassó M, Rubio M, Caballeria J, Pares A, Rodés J, Fernández-Checa JC. Enhanced DNA binding and activation of transcription factors NF-κB and AP-1 by acetaldehyde in HepG2 cells. J Biol Chem 2000;272:14684-14690.
16. Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Invest 2001;107:7-11.
17. DeLeve L, Kaplowitz N. Importance and regulation of hepatic glutathione. Semin Liver Dis 1990;10:251-266.
18. Griffith OW, Meister A. Origin and turnover of mitochondrial glutathione. Proc Natl Acad Sci U S A 1985;82:4668-4672.
19. Martensson J, Lai JCK, Meister A. High-affinity transport of glutathione is part of a multicomponent system essential for mitochondrial function. Proc Natl Acad Sci U S A 1990;87:7185-7189.
20. Colell A, García-Ruiz C, Morales A, Ballesta A, Ookhtens M, Rodés J, Kaplowitz N, Fernández-Checa JC. Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanolfed treated rats; effect of membrane physical properties and S-adenosyl-l-methionine. Hepatotogy 1997;26:699-708.
21. Colell A, Coll O, García-Ruiz C, Paris R, Tiribelli C, Kaplowitz N, Fernández-Checa JC. Tauroursodeoxycholic acid protects hepatocytes from ethanol-fed rats against tumor necrosis factor-induced cell death by replenishing mitochondrial glutathione. Hepatology 2001;34:964-971.
22. Pastorino JG, Hoek JW. Ethanol potentiates tumor necrosis factor cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition. Hepatology 2000;31:1141-1152.
23. Colell A, García-Ruiz C, Miranda M, Ardite E, Mari M, Morales A, Corrales F, Kaplowitz N, Fernández-Checa JC. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 1998;115:1541-1551.
24. Nakagami M, Wheeler MD, Bradford BU, Uesugi T, Mason RP, Connor HD, Dikalova A, Kadiiska M, Thurman RG. Overexpression of manganese superoxide dismutase prevents alcohol-incluced injury in the rat. J Biol Chem 2001;276:36664-36672.
25. Hirano T, Kaplowitz N, Tsukamoto H, Kamimura S, Fernández-Cheda JC. Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease. Hepatology 1991;16:1423-1427.
26. Tsukamoto H, Lu SC. Current concepts in the pathogenesis of alcoholic liver disease. FASEB J 2001;15:1335-1349.
27. Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 2000;101:451-454.
28. Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 1999;13:1211-1233.
29. Doerrler WT, Lehrman MA. Regulation of the dolicohol pathway in human fibroblasts by the endoplasmic reticulum unfolded protein response. Proc Natl Acad Sci U S A 1999;96:13050-13055.
30. Werstuck GH; Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, Austin RC. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001;107:1263-1273.
31. Clemens DL, Halgard CM, Miles RR, Sorrell MF, Tuma DJ. Establishment of a recombinant hepatic cell line stably expressing alcohol dehydrogenase. Arch Biochem Biophys 1995;321:311-318.
32. Cui L, Yoon S, Schinazi RF, Sommadossi JP. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-(-d-arabinofuranosyl)-5-iodouracil in human liver cells. J Clin Invest 1995;95:555-563.
33. García-Ruiz C, Fernández-Checa JC, Kaplowitz N. Bidirectional mechanism of plasma membrane transport of reduced glutathione in intact rat hepatocytes and isolated membrane vesicles. J Biol Chem 1992;267:22256-22264.
34. Pernes JF, Nurit Y, Heaulme M. Lipids: thin layer chromatographic separation in twelve fractions by three successive unidirectional developments on the same plate. J Chromatogr 1980;181:254-261.
35. Rudel LL, Morris MD. Determination of cholesterol using O-phthaladehyde. J Lipid Res 1973;14:364-366.
36. Metcalfe LD, Schmidt AA. The rapid preparation of fatty acid esters for gas chromatographic analices. Anal Chem 1961;33:363-364.
37. Van Blitterswijk WJ, van Hoeven RP, vander Meer BW. Lipid structural order parameters (reciprocal fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim Biophys Acta 1981;644:323-332.
38. Martinez F, Eschegoyen S, Briones R, Cuellar A. Cholesterol increase in mitochondria: a new method of cholesterol incorporation. J Lipid Res 1988;29:1005-1011.
39. Kosower ER, Kosower NS, Wegman P. Membrane mobility agents IV. The mechanism of particle-cell and cell-cell fusion. Biochim Biophys Acta 1977;471:311-319.
40. Scharnagl H, Schinker R, Gierens H, Nauck M, Wieland H, Marz W. Effect of atorvastating, simvastatin and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells. Biochem Pharmacol 2001;62:1545-1555.
41. Griffiths EJ, Halestrap AP. Further evidence that cyclosporin A protects mitochondria from calcium overload by inhibiting a matriz peptidyl-prolyl cis-trans isomerase. Implications for the immunosuppresive and toxic effects of cyclosporin. Biochem J 1991;274:611-614.
42. García-Ruiz C, Morales A, Colell A, Rodes J, Yi Y, Kaplowitz N, Fernández-Checa JC. Evidence that the rat hepatic mitochondrial carrier is distinct from the sinusoidal and canalicular transporters for reduced glutathione. J Biol Chem 1995;270:15946-15949.
43. Chen Z, Lash LH. Evidence for mitochondrial uptake of glutathione by dicarboxylate and 2-oxoglutarate carriers. J Pharmacol Exp Ther 1998;285:608-618.
44. Chen Z, Putt DA, Lash LH. Enrichment and functional reconstitution of glutathione transport activity from rabbit kidney mitochondria: further evidence for the role of the dicarboxylate and 2-oxoglutarate carriers in mitochondrial glutathione transport. Arch Biochem Biophys 2000;373:193-202.
45. Clemens DL, Forman A, Jerrells TR, Sorrell MF, Tuma DJ. Relationship between acetaldehyde levels and cell survival in ethanol-metabolizing hepatoma cells. Hepatology 2002;35:1196-1204.
46. Ricchelli F, Gobbo S, Moreno G, Salet C. Changes of the fluidity of mitochondrial membranes induced by the permeability transition. Biochemistry 1999;38:9295-9300.
47. Hill DB, Schmidt J, Shedelofsky SI, Cohen DA, McClain CJ. In vitro tumor necrosis factor cytotoxicity in HepG2 liver cells. Hepatology 1995;21:1114-1119.
48. Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J Biol Chem 1992;267:8834-8839.
49. Lemasters JJ. Mechanisms of hepatic toxicity V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol 1999;276:G1-G6.
50. Pastorino JG, Marcivenviciute A, Cahill A, Hoek JB. Potentiation by chronic ethanol treatment of the mitochondrial permeability transition. Biochem Biophys Res Commun 1999;265:405-409.
51. Costantini P, Belzacq AS, Vieira HL, Larochetter N, de Pablo MA, Zamzami N, Susin SA, Brenner C, Kroemer G. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene 2000;13:307-314.
52. Rao RV, Castro-Obregon S, Frankowski H, Schuler M, Stoka V, del Rio G, Bredesen DE, Ellerby HM. Coupling endoplasmic reticulum stress to the cell death program; an apaf-1-independent intrinsic pathway. J Biol Chem 2002;277:21836-21842.
53. You M, Fischer M, Deeg MA, Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem 2002;277:29342-29347.
54. Chitturi S, George J. Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, anti-diabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs. Semin Liver Dis 2002;22:169-183.